Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease
Eligible age
All ages
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The overall short-term goals of this project include the following: 1) identify the genes that are key to the function of respiratory cilia to protect the normal lung; and 2) the effects of genetic mutations that adversely affect ciliary function and cause primary ciliary dyskinesia (PCD), which results in life-shortening lung disease. The long-term goal of this project is to develop better understanding of the underlying genetic variability that adversely modifies ciliary function, and predisposes to common airway diseases, such as asthma and chronic obstructive pulmonary disease.
Sponsor: University of North Carolina, Chapel Hill
You may qualify if…
- ✓ Patients who have a high suspicion for the diagnosis of PCD, based on clinical features
- ✓ Healthy Volunteers who have a family member with confirmed PCD.
Where it's recruiting
Chapel Hill
Source: ClinicalTrials.gov · NCT00807482 · last updated 2026-06-29